Financhill
Back

BioCryst Pharmaceuticals Vs. Avidity Biosciences Industry Stock Comparison

Sell
38

BCRX
BioCryst Pharmaceuticals

Last Price:
8.16
Seasonality Move:
-9.69%
Sell
33

RNA
Avidity Biosciences

Last Price:
45.67
Seasonality Move:
-1.3%
Sell
38
BioCryst Pharmaceuticals (BCRX) is a Sell

Is BioCryst Pharmaceuticals a Buy, Sell or Hold?

  • The current BioCryst Pharmaceuticals [BCRX] share price is $8.16. The Score for BCRX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • BCRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Avidity Biosciences (RNA) is a Sell

Is Avidity Biosciences a Buy, Sell or Hold?

  • The current Avidity Biosciences [RNA] share price is $45.68. The Score for RNA is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • RNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BCRX Stock Price Chart

What is BioCryst Pharmaceuticals's stock price today?

  • The BioCryst Pharmaceuticals share price today is $8.16
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BCRX is experiencing slight buying pressure.

RNA Stock Price Chart

What is Avidity Biosciences's stock price today?

  • The Avidity Biosciences share price today is $45.68
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing slight buying pressure.

BCRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.06 Buy
Relative Strength Index (14 RSI): 57.44 Buy
Chaikin Money Flow: 110287 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.74 - 8.32) Buy
Bollinger Bands (100): (5.85 - 7.91) Buy

RNA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.03 Buy
Relative Strength Index (14 RSI): 62 Buy
Chaikin Money Flow: 402350 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.19 - 44.69) Buy
Bollinger Bands (100): (30.3 - 45.36) Buy

BCRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.89 Buy
20-day SMA: 8.09 Buy
50-day SMA: 7.74 Buy
200-day SMA: 6.18 Buy
8-day EMA: 7.98 Buy
20-day EMA: 7.96 Buy
50-day EMA: 7.64 Buy
200-day EMA: 6.77 Buy

RNA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 42.33 Buy
20-day SMA: 42.39 Buy
50-day SMA: 43.82 Buy
200-day SMA: 26.96 Buy
8-day EMA: 43.04 Buy
20-day EMA: 42.7 Buy
50-day EMA: 41.84 Buy
200-day EMA: 30.49 Buy

BioCryst Pharmaceuticals Earnings Growth & BCRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.66 per share, and an increase next year of $0.23 per share.

Avidity Biosciences Earnings Growth & RNA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.20 per share, and a decrease next year of $0.17 per share.

BioCryst Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Avidity Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):